JP2016505018A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505018A5 JP2016505018A5 JP2015552834A JP2015552834A JP2016505018A5 JP 2016505018 A5 JP2016505018 A5 JP 2016505018A5 JP 2015552834 A JP2015552834 A JP 2015552834A JP 2015552834 A JP2015552834 A JP 2015552834A JP 2016505018 A5 JP2016505018 A5 JP 2016505018A5
- Authority
- JP
- Japan
- Prior art keywords
- individual
- combination according
- combination
- paclitaxel
- albumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361751820P | 2013-01-11 | 2013-01-11 | |
| US61/751,820 | 2013-01-11 | ||
| US201361752355P | 2013-01-14 | 2013-01-14 | |
| US61/752,355 | 2013-01-14 | ||
| US13/794,480 | 2013-03-11 | ||
| US13/794,480 US9511046B2 (en) | 2013-01-11 | 2013-03-11 | Methods of treating pancreatic cancer |
| PCT/US2014/011145 WO2014110443A1 (en) | 2013-01-11 | 2014-01-10 | Methods of treating pancreatic cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018028611A Division JP6697017B2 (ja) | 2013-01-11 | 2018-02-21 | 膵臓がんの処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505018A JP2016505018A (ja) | 2016-02-18 |
| JP2016505018A5 true JP2016505018A5 (enExample) | 2017-02-16 |
| JP6342918B2 JP6342918B2 (ja) | 2018-06-13 |
Family
ID=51165317
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015552834A Active JP6342918B2 (ja) | 2013-01-11 | 2014-01-10 | 膵臓がんの処置方法 |
| JP2018028611A Active JP6697017B2 (ja) | 2013-01-11 | 2018-02-21 | 膵臓がんの処置方法 |
| JP2019033910A Pending JP2019081790A (ja) | 2013-01-11 | 2019-02-27 | 膵臓がんの処置方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018028611A Active JP6697017B2 (ja) | 2013-01-11 | 2018-02-21 | 膵臓がんの処置方法 |
| JP2019033910A Pending JP2019081790A (ja) | 2013-01-11 | 2019-02-27 | 膵臓がんの処置方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US9511046B2 (enExample) |
| EP (1) | EP2943192B9 (enExample) |
| JP (3) | JP6342918B2 (enExample) |
| KR (1) | KR102205710B1 (enExample) |
| CN (2) | CN105025893A (enExample) |
| AU (1) | AU2013203699B2 (enExample) |
| BR (1) | BR112015016681A8 (enExample) |
| CA (1) | CA2897589C (enExample) |
| CY (1) | CY1124273T1 (enExample) |
| DK (1) | DK2943192T3 (enExample) |
| ES (1) | ES2878145T3 (enExample) |
| HK (1) | HK1216853A1 (enExample) |
| HR (1) | HRP20211062T1 (enExample) |
| HU (1) | HUE056612T2 (enExample) |
| IL (2) | IL239739A0 (enExample) |
| LT (1) | LT2943192T (enExample) |
| MX (1) | MX382017B (enExample) |
| NZ (2) | NZ630230A (enExample) |
| PL (1) | PL2943192T3 (enExample) |
| PT (1) | PT2943192T (enExample) |
| RS (1) | RS62076B1 (enExample) |
| SI (1) | SI2943192T1 (enExample) |
| SM (1) | SMT202100377T1 (enExample) |
| WO (1) | WO2014110443A1 (enExample) |
| ZA (1) | ZA201504877B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1585548B1 (en) | 2002-12-09 | 2018-06-27 | Abraxis BioScience, LLC | Compositions and methods of delivery of pharmacological agents |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| SI3248600T1 (sl) | 2005-02-18 | 2020-09-30 | Abraxis Bioscience, Llc | Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija |
| PL1931321T3 (pl) | 2005-08-31 | 2019-08-30 | Abraxis Bioscience, Llc | Kompozycje zawierające słabo rozpuszczalne w wodzie środki farmaceutyczne i środki przeciwdrobnoustrojowe |
| EP3470071A1 (en) | 2006-12-14 | 2019-04-17 | Abraxis BioScience, LLC | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| WO2008150532A1 (en) * | 2007-06-01 | 2008-12-11 | Abraxis Bioscience, Llc | Methods and compositions for treating recurrent cancer |
| MX378130B (es) | 2009-04-15 | 2025-03-10 | Abraxis Bioscience Llc | Métodos y composiciones de nanopartículas sin priones. |
| PT2552438T (pt) | 2010-03-26 | 2016-07-07 | Abraxis Bioscience Llc | Métodos de tratamento de carcinoma hepatocelular |
| EP3141245A1 (en) | 2010-03-29 | 2017-03-15 | Abraxis BioScience, LLC | Methods of treating cancer |
| AU2011232862B2 (en) | 2010-03-29 | 2016-03-03 | Abraxis Bioscience, Llc | Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| BR112012030909A2 (pt) | 2010-06-04 | 2020-08-18 | Abraxis Bioscience, Llc | métodos de tratamento de câncer pancreático |
| AU2011264590B2 (en) * | 2010-06-07 | 2016-12-15 | Abraxis Bioscience, Llc | Combination therapy methods for treating proliferative diseases |
| AU2012249371B2 (en) | 2011-04-28 | 2017-06-08 | Abraxis Bioscience, Llc | Intravascular delivery of nanoparticle compositions and uses thereof |
| RU2705998C2 (ru) | 2011-12-14 | 2019-11-13 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Применение полимерных эксципиентов для лиофилизации или заморозки частиц |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| US10744110B2 (en) | 2013-03-12 | 2020-08-18 | Abraxis Bioscience, Llc | Methods of treating lung cancer |
| CA2903548A1 (en) | 2013-03-14 | 2014-09-25 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| AU2016270558B2 (en) | 2015-06-04 | 2020-08-13 | Crititech, Inc. | Nozzle assembly and methods for use |
| KR102606071B1 (ko) | 2015-06-29 | 2023-11-27 | 아브락시스 바이오사이언스, 엘엘씨 | 상피양 세포 종양을 치료하는 방법 |
| EP3316871A4 (en) * | 2015-06-30 | 2019-02-20 | The Trustees of Columbia University in the City of New York | TALKED COMPOSITION AND USES THEREOF |
| CA3018989A1 (en) | 2016-04-04 | 2017-10-12 | Crititech, Inc. | Methods for solid tumor treatment |
| US20200071415A1 (en) * | 2017-03-17 | 2020-03-05 | Imclone Llc | Combination therapy for pancreatic cancer |
| CN110730679A (zh) | 2017-06-09 | 2020-01-24 | 克里蒂泰克公司 | 囊内注射抗肿瘤颗粒治疗上皮囊肿 |
| JP6840869B2 (ja) | 2017-06-14 | 2021-03-10 | クリチテック，インコーポレイテッド | 肺障害の治療方法 |
| WO2019070850A1 (en) | 2017-10-03 | 2019-04-11 | Crititech, Inc. | LOCAL ADMINISTRATION OF ANINEOPLASTIC PARTICLES IN COMBINATION WITH SYSTEMIC DELIVERY OF IMMUNOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER |
| KR102837015B1 (ko) | 2018-03-20 | 2025-07-23 | 아브락시스 바이오사이언스, 엘엘씨 | mTOR 억제제 및 알부민의 나노입자의 투여를 통한 중추 신경계 장애의 치료 방법 |
| GB201908352D0 (en) * | 2019-06-11 | 2019-07-24 | Innovation Ulster Ltd | Sonodynamic therapy |
| EP4007640A4 (en) * | 2019-08-01 | 2023-10-04 | New York University | Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeutics |
| CA3158764A1 (en) | 2019-10-28 | 2021-05-06 | Abraxis Bioscience, Llc | Pharmaceutical compositions of albumin and rapamycin |
| EP4100035A1 (en) * | 2020-02-04 | 2022-12-14 | Swedish Orphan Biovitrum AB (publ) | Pdac treatment regimen |
| AU2023435819A1 (en) * | 2023-03-09 | 2025-10-02 | Minneamrita Therapeutics Llc | Drug combination for treatment of pancreatic cancer |
| CN117099681B (zh) * | 2023-08-28 | 2024-07-05 | 南京农业大学 | 一种利用紫杉醇加倍玉米单倍体的方法 |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| DK0693924T4 (da) | 1993-02-22 | 2008-08-04 | Abraxis Bioscience Inc | Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil |
| US5439686A (en) | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US5362478A (en) | 1993-03-26 | 1994-11-08 | Vivorx Pharmaceuticals, Inc. | Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell |
| US5650156A (en) | 1993-02-22 | 1997-07-22 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of nutriceuticals and compositions useful therefor |
| US20030068362A1 (en) | 1993-02-22 | 2003-04-10 | American Bioscience, Inc. | Methods and formulations for the delivery of pharmacologically active agents |
| US5997904A (en) | 1993-02-22 | 1999-12-07 | American Bioscience, Inc. | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6528067B1 (en) | 1993-02-22 | 2003-03-04 | American Bioscience, Inc. | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| US6565842B1 (en) | 1995-06-07 | 2003-05-20 | American Bioscience, Inc. | Crosslinkable polypeptide compositions |
| US20070092563A1 (en) | 1996-10-01 | 2007-04-26 | Abraxis Bioscience, Inc. | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| NZ502500A (en) | 1997-06-27 | 2002-03-28 | Vivorx Pharmaceuticals Inc | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| US20030199425A1 (en) | 1997-06-27 | 2003-10-23 | Desai Neil P. | Compositions and methods for treatment of hyperplasia |
| AU777528B2 (en) | 1999-04-22 | 2004-10-21 | Abraxis Bioscience, Llc | Long term administration of pharmacologically active agents |
| CA2684454A1 (en) | 1999-05-21 | 2000-11-18 | American Bioscience, Llc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| ITMI20001107A1 (it) | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
| ITMI20020681A1 (it) * | 2002-03-29 | 2003-09-29 | Acs Dobfar Spa | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina |
| EP1585548B1 (en) | 2002-12-09 | 2018-06-27 | Abraxis BioScience, LLC | Compositions and methods of delivery of pharmacological agents |
| KR20150108943A (ko) | 2002-12-09 | 2015-09-30 | 아브락시스 바이오사이언스, 엘엘씨 | 약리학적 물질의 조성물 및 그 전달방법 |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| AU2012201568B2 (en) | 2005-02-18 | 2014-07-31 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| US20070166388A1 (en) | 2005-02-18 | 2007-07-19 | Desai Neil P | Combinations and modes of administration of therapeutic agents and combination therapy |
| SI3248600T1 (sl) | 2005-02-18 | 2020-09-30 | Abraxis Bioscience, Llc | Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija |
| US7691392B2 (en) | 2005-04-29 | 2010-04-06 | Kosan Biosciences Incorporated | Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either |
| EP3527202A1 (en) | 2005-08-31 | 2019-08-21 | Abraxis BioScience, LLC | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| PL1931321T3 (pl) | 2005-08-31 | 2019-08-30 | Abraxis Bioscience, Llc | Kompozycje zawierające słabo rozpuszczalne w wodzie środki farmaceutyczne i środki przeciwdrobnoustrojowe |
| JP2007297339A (ja) * | 2006-04-29 | 2007-11-15 | Torii Yakuhin Kk | 癌を治療又は検査するための医薬 |
| EP2056812A1 (en) | 2006-08-31 | 2009-05-13 | Abraxis BioScience, LLC | Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases |
| EP3470071A1 (en) | 2006-12-14 | 2019-04-17 | Abraxis BioScience, LLC | Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| LT2481402T (lt) | 2007-03-07 | 2018-10-25 | Abraxis Bioscience, Llc | Nanodalelė, apimanti rapamiciną ir albuminą, kaip priešvėžinį agentą |
| CA2686736A1 (en) | 2007-05-03 | 2008-11-13 | Abraxis Bioscience, Llc | Nanoparticle compositions comprising rapamycin for treating pulmonary hypertension |
| WO2008150532A1 (en) | 2007-06-01 | 2008-12-11 | Abraxis Bioscience, Llc | Methods and compositions for treating recurrent cancer |
| CA2721153C (en) | 2008-04-10 | 2018-10-02 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| RU2010145529A (ru) | 2008-04-10 | 2012-05-20 | АБРАКСИС БАЙОСАЙЕНС ЭлЭлСи (US) | Композиции гидрофобных производных таксана и их применение |
| ES2588194T3 (es) * | 2008-04-11 | 2016-10-31 | Seattle Genetics, Inc. | Detección y tratamiento de cáncer pancreático, de ovario y otros cánceres |
| MX2011006167A (es) | 2008-12-11 | 2011-07-28 | Abraxis Bioscience Llc | Combinaciones y modos de administracion de agentes terapeuticos y terapia de combinacion. |
| GB0900555D0 (en) | 2009-01-14 | 2009-02-11 | Topotarget As | New methods |
| JP5725563B2 (ja) | 2009-03-13 | 2015-05-27 | アブラクシス バイオサイエンス， エルエルシー | チオコルヒチン誘導体との組み合わせ療法 |
| CA2758200A1 (en) | 2009-04-10 | 2010-10-14 | Abraxis Bioscience, Llc | Nanoparticle formulations and uses thereof |
| MX378130B (es) | 2009-04-15 | 2025-03-10 | Abraxis Bioscience Llc | Métodos y composiciones de nanopartículas sin priones. |
| CA2960887C (en) * | 2009-05-28 | 2018-09-04 | Abraxis Bioscience, Llc | Use of 2 anti-sparc antibodies to predict response to chemotherapy |
| MX340670B (es) * | 2009-08-25 | 2016-07-20 | Abraxis Bioscience Llc * | Terapia combinada con composiciones de nanoparticulas de taxano e inhibidores de hedgehog. |
| JP2011079788A (ja) * | 2009-10-08 | 2011-04-21 | Oita Univ | 膵癌に対する選択的膵動脈制癌剤注入療法と全身化学療法との併用療法、およびそれに使用する膵癌治療薬 |
| NZ601324A (en) * | 2010-01-05 | 2014-10-31 | Vascular Biogenics Ltd | Methods for use of a specific anti-angiogenic adenoviral agent |
| PT2552438T (pt) | 2010-03-26 | 2016-07-07 | Abraxis Bioscience Llc | Métodos de tratamento de carcinoma hepatocelular |
| EP3141245A1 (en) | 2010-03-29 | 2017-03-15 | Abraxis BioScience, LLC | Methods of treating cancer |
| AU2011232862B2 (en) | 2010-03-29 | 2016-03-03 | Abraxis Bioscience, Llc | Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| JP2013523712A (ja) | 2010-03-30 | 2013-06-17 | クラヴィス・ファルマ・アーエスアー | ゲムシタビン−５’−エライデートを用いて癌を治療又は緩和するための方法及び組成物 |
| ES2639038T3 (es) | 2010-06-02 | 2017-10-25 | Abraxis Bioscience, Llc | Métodos para el tratamiento de cáncer de vejiga |
| BR112012030909A2 (pt) | 2010-06-04 | 2020-08-18 | Abraxis Bioscience, Llc | métodos de tratamento de câncer pancreático |
| AU2011264590B2 (en) | 2010-06-07 | 2016-12-15 | Abraxis Bioscience, Llc | Combination therapy methods for treating proliferative diseases |
| AU2012249371B2 (en) | 2011-04-28 | 2017-06-08 | Abraxis Bioscience, Llc | Intravascular delivery of nanoparticle compositions and uses thereof |
| RU2705998C2 (ru) | 2011-12-14 | 2019-11-13 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Применение полимерных эксципиентов для лиофилизации или заморозки частиц |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US20140186447A1 (en) | 2012-12-28 | 2014-07-03 | Abraxis Bioscience, Llc | Nanoparticle compositions of albumin and paclitaxel |
| US20140199405A1 (en) | 2013-01-11 | 2014-07-17 | Abraxis Bioscience, Llc | Method for treating cancer based on mutation status of k-ras |
| US20140199404A1 (en) | 2013-01-11 | 2014-07-17 | Abraxis Bioscience, Llc | Method for treating cancer based on level of a nucleoside transporter |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| MX377729B (es) | 2013-02-11 | 2025-03-11 | Abraxis Bioscience Llc | Métodos para tratamiento del melanoma. |
| US10744110B2 (en) | 2013-03-12 | 2020-08-18 | Abraxis Bioscience, Llc | Methods of treating lung cancer |
| WO2014143613A1 (en) | 2013-03-13 | 2014-09-18 | Abraxis Bioscience, Llc | Methods of treatment of pediatric solid tumor |
| CA2903548A1 (en) | 2013-03-14 | 2014-09-25 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
| US20170202782A1 (en) | 2014-04-06 | 2017-07-20 | Abraxis Bioscience, Llc | Combination therapy comprising nanoparticles of a taxane and albumin with abt-263 in methods for treating cancer |
| US20180064679A1 (en) | 2015-03-05 | 2018-03-08 | Abraxis Bioscience, Llc | Method for treating cancer based on level of glucocorticoid receptor |
| IL256326B2 (en) | 2015-06-29 | 2024-09-01 | Abraxis Bioscience Llc | Biomarkers for nanoparticle compositions |
| KR102606071B1 (ko) | 2015-06-29 | 2023-11-27 | 아브락시스 바이오사이언스, 엘엘씨 | 상피양 세포 종양을 치료하는 방법 |
| AU2016287508B2 (en) | 2015-06-29 | 2021-10-14 | Abraxis Bioscience, Llc | Methods of treating solid tumors using nanoparticle MTOR inhibitor combination therapy |
| US20170181988A1 (en) | 2015-12-23 | 2017-06-29 | Cipla Limited | Methods for the treatment of bladder cancer |
-
2013
- 2013-03-11 US US13/794,480 patent/US9511046B2/en active Active
- 2013-04-11 AU AU2013203699A patent/AU2013203699B2/en active Active
-
2014
- 2014-01-10 SM SM20210377T patent/SMT202100377T1/it unknown
- 2014-01-10 RS RS20210823A patent/RS62076B1/sr unknown
- 2014-01-10 CN CN201480013217.4A patent/CN105025893A/zh active Pending
- 2014-01-10 EP EP14737791.5A patent/EP2943192B9/en not_active Revoked
- 2014-01-10 HK HK16104890.5A patent/HK1216853A1/zh unknown
- 2014-01-10 HR HRP20211062TT patent/HRP20211062T1/hr unknown
- 2014-01-10 SI SI201431853T patent/SI2943192T1/sl unknown
- 2014-01-10 KR KR1020157021320A patent/KR102205710B1/ko active Active
- 2014-01-10 WO PCT/US2014/011145 patent/WO2014110443A1/en not_active Ceased
- 2014-01-10 MX MX2015008898A patent/MX382017B/es unknown
- 2014-01-10 BR BR112015016681A patent/BR112015016681A8/pt not_active Application Discontinuation
- 2014-01-10 CN CN201910067315.0A patent/CN109793728A/zh active Pending
- 2014-01-10 LT LTEP14737791.5T patent/LT2943192T/lt unknown
- 2014-01-10 DK DK14737791.5T patent/DK2943192T3/da active
- 2014-01-10 PT PT147377915T patent/PT2943192T/pt unknown
- 2014-01-10 NZ NZ630230A patent/NZ630230A/en unknown
- 2014-01-10 CA CA2897589A patent/CA2897589C/en active Active
- 2014-01-10 ES ES14737791T patent/ES2878145T3/es active Active
- 2014-01-10 NZ NZ734971A patent/NZ734971A/en unknown
- 2014-01-10 JP JP2015552834A patent/JP6342918B2/ja active Active
- 2014-01-10 HU HUE14737791A patent/HUE056612T2/hu unknown
- 2014-01-10 PL PL14737791T patent/PL2943192T3/pl unknown
-
2015
- 2015-07-01 IL IL239739A patent/IL239739A0/en unknown
- 2015-07-07 ZA ZA2015/04877A patent/ZA201504877B/en unknown
-
2016
- 2016-10-06 US US15/287,613 patent/US9855220B2/en active Active
-
2017
- 2017-11-21 US US15/820,022 patent/US10328031B2/en active Active
-
2018
- 2018-02-21 JP JP2018028611A patent/JP6697017B2/ja active Active
-
2019
- 2019-02-27 JP JP2019033910A patent/JP2019081790A/ja active Pending
-
2020
- 2020-02-26 IL IL272905A patent/IL272905A/en unknown
-
2021
- 2021-06-30 CY CY20211100585T patent/CY1124273T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016505018A5 (enExample) | ||
| HRP20211062T1 (hr) | Metode liječenja raka gušterače koje uključuju paklitaksel i gemcitabin | |
| MX2015011752A (es) | Metodos para tratar cancer de pulmon. | |
| Li et al. | Recent advances in targeted nanoparticles drug delivery to melanoma | |
| JP2013523656A5 (enExample) | ||
| HRP20160609T1 (hr) | Postupci liječenja hepatocelularnog karcinoma | |
| JP2013527232A5 (enExample) | ||
| HK1217292A1 (zh) | 基於k- ras的突变状态治疗癌症的方法 | |
| JP2013503174A5 (enExample) | ||
| MY188911A (en) | Methods of treating bladder cancer | |
| JP2013518815A5 (enExample) | ||
| CR20120528A (es) | Métodos para tratar el cáncer | |
| WO2008137148A3 (en) | Methods and compositions for treating pulmonary hypertension | |
| JP2008274047A5 (enExample) | ||
| WO2015035094A8 (en) | Methods of treatment of cancer by continuous infusion of coenzyme q10 | |
| JP2017527582A5 (enExample) | ||
| Amin et al. | Evaluation of acute and subchronic toxicity of silver nanoparticles in normal and irradiated animals | |
| RU2012107095A (ru) | ИНГИБИРОВАНИЕ МЕТАСТАЗИРОВАНИЯ ОПУХОЛИ ПРИ ПОМОЩИ АНТАГОНИСТОВ Bv8 ИЛИ G-CSF | |
| JP2018513155A5 (enExample) | ||
| JP2019529520A5 (enExample) | ||
| RU2019105574A (ru) | Противоопухолевый агент, усилитель противоопухолевого действия и противоопухолевый набор | |
| JP2016533373A5 (enExample) | ||
| JP2017516827A5 (enExample) | ||
| JP2015146883A5 (enExample) | ||
| JP2013522350A5 (enExample) |